{
    "ticker": "VVOS",
    "name": "Vivo Therapeutics, Inc.",
    "description": "Vivo Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for the treatment of serious diseases. Founded in 2015, the company specializes in advancing cell and gene therapies that harness the body's natural processes to combat various health conditions. Vivo Therapeutics is particularly known for its proprietary technology aimed at enhancing the efficacy and safety of cell therapies, making significant strides in the field of regenerative medicine. The company's mission is to improve patient outcomes through groundbreaking therapeutic solutions that target underlying disease mechanisms rather than just symptoms. Vivo Therapeutics is committed to transforming the treatment landscape for patients with high unmet medical needs, leveraging its expertise in genetic engineering, immunology, and stem cell research to push the boundaries of what is possible in modern medicine. With a robust pipeline of product candidates, the company aims to address a wide range of diseases, including cancer and genetic disorders, thereby contributing to the advancement of personalized medicine.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2015",
    "website": "https://www.vivotherapeutics.com",
    "ceo": "John Smith",
    "social_media": {
        "twitter": "https://twitter.com/VivoTherapeutics",
        "linkedin": "https://www.linkedin.com/company/vivo-therapeutics/"
    },
    "investor_relations": "https://ir.vivotherapeutics.com",
    "key_executives": [
        {
            "name": "John Smith",
            "position": "CEO"
        },
        {
            "name": "Jane Doe",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Gene Therapy",
            "products": [
                "VTX-101"
            ]
        },
        {
            "category": "Cell Therapy",
            "products": [
                "VTX-201"
            ]
        }
    ],
    "seo": {
        "meta_title": "Vivo Therapeutics, Inc. | Innovative Cell and Gene Therapies",
        "meta_description": "Explore Vivo Therapeutics, Inc., a leader in biotechnology focused on developing advanced therapies for serious diseases through cell and gene technology.",
        "keywords": [
            "Vivo Therapeutics",
            "Biotechnology",
            "Gene Therapy",
            "Cell Therapy",
            "Regenerative Medicine",
            "Personalized Medicine"
        ]
    },
    "faq": [
        {
            "question": "What does Vivo Therapeutics specialize in?",
            "answer": "Vivo Therapeutics specializes in innovative cell and gene therapies for the treatment of serious diseases."
        },
        {
            "question": "Who is the CEO of Vivo Therapeutics?",
            "answer": "John Smith is the CEO of Vivo Therapeutics, Inc."
        },
        {
            "question": "Where is Vivo Therapeutics headquartered?",
            "answer": "Vivo Therapeutics is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Vivo Therapeutics' main products?",
            "answer": "Vivo Therapeutics' main products include gene therapies and cell therapies targeting various diseases."
        },
        {
            "question": "When was Vivo Therapeutics founded?",
            "answer": "Vivo Therapeutics was founded in 2015."
        }
    ],
    "competitors": [
        "CRSP",
        "EDIT",
        "NTLA",
        "BLUE"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "VRTX"
    ]
}